RenovoRx's market cap is currently $48.74M. The company's EPS TTM is $-0.08; its P/E ratio is ―; RenovoRx is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
